Skip to main content

Enochian Biosciences, Inc. (ENOB)

NASDAQ: ENOB · IEX Real-Time Price · USD
6.86
-0.35 (-4.85%)
After-hours:Sep 24, 2021 5:46 PM EDT
7.21
0.23 (3.30%)
At close: Sep 24, 4:00 PM
Market Cap382.37M
Revenue (ttm)n/a
Net Income (ttm)-13.46M
Shares Out51.95M
EPS (ttm)-0.29
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume203,141
Open7.26
Previous Close6.98
Day's Range7.07 - 7.60
52-Week Range2.60 - 12.99
Beta0.37
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About ENOB

Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, focuses on development of human therapeutics for infectious diseases and cancers. The company's lead candidate include ENOB-HV-01 for autologous HIV curative treatment. Its pipeline development products consist of ENOB-HV-11, a preventive HIV vaccine; and ENOB-HV-12, a therapeutic HIV vaccine. The company's pipeline development products also include ENOB-HB-01, a coopting Hepatitis B polymerase; ENOB-DC-01, an off-the-shelf DC vaccine pulsed with MCV lysate; ENOB-DC-11 inno...

IndustryBiotechnology
Employees10
Stock ExchangeNASDAQ
Ticker SymbolENOB
Full Company Profile

Financial Performance

Financial Statements

News

Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences' Scientific Advisory Board for Potent...

LOS ANGELES, Aug. 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene-modified cellular and immune therapies for infectious diseases and cancer, announced the a...

3 weeks ago - GlobeNewsWire

Distinguished Scientific and Clinical Leader to Join Enochian BioSciences' Hepatitis B Cure Scientific Advisory Board

LOS ANGELES, Aug. 23, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, a company focused on gene modified cellular and immune therapies for infectious diseases and cancer, announced that ...

1 month ago - GlobeNewsWire

Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer

Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm Enochian BioSciences' Scientific Approach Dr. Dybul's Deep and Prestigious Scientific Research Expertise Helps to Affirm En...

2 months ago - GlobeNewsWire

Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program

Enochian BioSciences Inc (NASDAQ: ENOB) has announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a potential cure of hepatitis B virus (HBV) infection. Written comments a...

2 months ago - Benzinga

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection

LOS ANGELES, July 12, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today anno...

2 months ago - GlobeNewsWire

Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity

LOS ANGELES, June 30, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today anno...

2 months ago - GlobeNewsWire

Why Enochian BioSciences Was a Winner on Monday

The company scores an exclusive license for new potential coronavirus treatment technology.

3 months ago - The Motley Fool

Why Enochian Biosciences, Raven Industries And GE Share Are Trading Higher Today

Enochian Biosciences Inc (NASDAQ:ENOB) shares are trading higher by 11.7% at $6.48 Monday morning after the company announced it acquired an exclusive license for an innovative technology to potentially...

Other symbols:GERAVN
3 months ago - Benzinga

Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology

Enochian BioSciences Inc (NASDAQ: ENOB) has acquired an exclusive license for a technology to potentially treat and prevent all variants of coronavirus, including the cause of COVID-19, as well as influ...

3 months ago - Benzinga

Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhal...

Request for Pre-Investigator New Drug Meeting to Be Submitted to FDA in Near Term Request for Pre-Investigator New Drug Meeting to Be Submitted to FDA in Near Term

3 months ago - GlobeNewsWire

Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV

LOS ANGELES, June 15, 2021 /PRNewswire/ -- (NASDAQ: ENOB) – A promising cure for HIV is moving one step closer to FDA approval. The novel approach to treating HIV in humans using cell therapy, developed...

3 months ago - PRNewsWire

Here's Why Enochian BioSciences Stock Skyrocketed Today

The biotech's experimental treatment for HIV could be a game changer.

3 months ago - The Motley Fool

Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today ann...

3 months ago - GlobeNewsWire

ENOB Stock: The HIV Treatment News That Has Enochain Biosciences Skyrocketing Today

Shares of ENOB stock are taking off on Monday after Enochain Biosciences received FDA acceptance for its vital HIV treatment. The post ENOB Stock: The HIV Treatment News That Has Enochain Biosciences Sk...

3 months ago - InvestorPlace

Hot Penny Stocks For Your Weekly Watchlist in June

Making a penny stocks watchlist this week? Check these 3 small-caps out The post Hot Penny Stocks For Your Weekly Watchlist in June appeared first on Penny Stocks to Buy, Picks, News and Information | P...

Other symbols:GSATMDIA
3 months ago - PennyStocks

Why Is Enochian BioSciences (ENOB) Stock Surging Today?

The FDA has accepted Enochian BioSciences Inc's (NASDAQ: ENOB) pre-IND (Investigational New Drug) request for a potential functional cure or treatment of HIV. Written comments are expected this Fall.

3 months ago - Benzinga

Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure

LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FD...

3 months ago - GlobeNewsWire

Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Vir...

LOS ANGELES, May 12, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced the release ...

4 months ago - GlobeNewsWire

A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Co...

LOS ANGELES, May 12, 2021 /PRNewswire/ -- (NASDAQ: ENOB) –  A novel approach to HIV cell therapy developed by Dr. Serhat Gumrukçu (Dr. Serhat), Director of the Seraph Research Institute (SRI), and his t...

4 months ago - PRNewsWire

Today's Biggest Pre-Market Movers: 10 Top Gainers and Losers on Thursday Morning

Pre-market movers this morning include some high-profile top gainers and losers. Take a look at this list that includes NFT stocks and EV plays.

5 months ago - InvestorPlace

Seraph Research Institute and Enochian BioSciences Publish a Case Report of Complete Remission of Recurrent Glioblast...

LOS ANGELES, March 24, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) – Seraph Research Institute (SRI) and Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infec...

6 months ago - GlobeNewsWire

Enochian BioSciences to Present to Investors at the H.C. Wainwright Global Life Sciences Conference

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Enochian BioSciences, a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that it will be m...

7 months ago - GlobeNewsWire

Enochian BioSciences to Present to Investors at 22nd Annual H.C. Wainwright Global Investment Conference

LOS ANGELES, Sept. 10, 2020 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) − Enochian BioSciences , a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today annou...

1 year ago - GlobeNewsWire

Here's Why Small-Cap Biopharma Enochian Is Surging Higher

Shares of Enochian Biosciences Inc (NASDAQ: ENOB) were trading more than 75% higher Monday in reaction to the company's announcement regarding a positive FDA meeting regarding its HIV candidate.

1 year ago - Benzinga

Enochian Bio’s HIV Treatment Is on Its Way With the FDA

Enochian BioSciences Inc. (NASDAQ: ENOB) shares more than doubled to start out the week after the company received a critical update from the U.S.

1 year ago - 24/7 Wall Street